Zheng-Rong Lu

This inventor holds 20 USPTO granted patents and 11 published patent applications and 3 EPO patents, primarily in Molecular Imaging. Top assignees: Case Western Reserve University, University of Utah Research Foundation. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zheng-Rong Lu. Retrieved from https://idiyas.com/inventor/zheng-rong-lu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 11)

% Patents Active = 85.0

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

Salt Lake City, UT (US) (2006 - 2010)
Beachwood, OH (US) (2015 - 2023)
Cleveland, OH (US) (2018 - 2024)

Company Filing History:

18 out of 1,364

Case Western Reserve University

patents

2 out of 1,687

University of Utah Research Foundation

patents

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Molecular Probes

Peptide Probes

Nucleic Acid Delivery

Ocular Disorders

Polysaccharide Conjugates

Targeting Peptides

CT Contrast Agents

MRI Contrast Agents

Extracellular Matrix

Oncoproteins

Biodegradable Agents

Macromolecular Imaging

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12599684 - MOLECULAR PROBES AND METHODS OF USE (2026-04-14),

2. 12576168 - PEPTIDE PET/SPECT PROBES SPECIFIC TO ONCOPROTEINS IN TUMOR EXTRACELLULAR MATRIX (2026-03-17),

3. 12378284 - Compositions and methods for the delivery of nucleic acids (2025-08-05),

4. 12161659 - Compositions and methods for the delivery of nucleic acids (2024-12-10),

5. 12060318 - Compositions and methods for the delivery of nucleic acids (2024-08-13),

6. 11793853 - Retinylamine derivitives for treatment of ocular disorders (2023-10-24),

7. 11738099 - Molecular probes and methods of use (2023-08-29),

8. 11407786 - Compositions and methods for the delivery of nucleic acids (2022-08-09),

9. 11129845 - Compositions and methods for the delivery of nucleic acids (2021-09-28),

10. 11065338 - Polysaccharide therapeutic conjugates (2021-07-20),

11. 10925980 - Molecular probes and methods of use (2021-02-23),

12. 10792374 - Compositions and methods for the delivery of nucleic acids (2020-10-06),

13. 10653801 - Targeting peptides and methods of use (2020-05-19),

14. 10471118 - Retinylamine derivitives for treatment of ocular disorders (2019-11-12),

15. 10226536 - Polysaccharide therapeutic conjugates (2019-03-12),

Title: Innovator Profile: Zheng-Rong Lu

Introduction: Zheng-Rong Lu is a prominent inventor based in Beachwood, OH, recognized for his significant contributions to the field of nucleic acid delivery systems. With a total of 18 patents, Lu has shown extraordinary creativity and innovation in developing advanced methodologies.

Latest Patents: Among his latest patents are notable works focusing on the delivery of nucleic acids. One of his patents describes a nanosized complex that includes siRNA combined with a unique compound, referred to by an innovative formula. Another crucial patent outlines a compound that embodies this formula, furthering the capability to efficiently deliver nucleic acids in various applications.

Career Highlights: Zheng-Rong Lu has had a distinguished career at esteemed institutions such as Case Western Reserve University and the University of Utah Research Foundation. His work at these research institutions has not only enriched his expertise but also contributed significantly to the advancement of scientific knowledge in his areas of focus.

Collaborations: Throughout his career, Zheng-Rong Lu has collaborated with talented individuals such as Zheng Han and Da Sun. These partnerships have fostered an environment of innovation and research excellence, leading to impactful advancements in the field.

Conclusion: Zheng-Rong Lu's dedication to innovation and his impressive portfolio of patents demonstrate his pivotal role in the development of new technologies in nucleic acid delivery. His contributions continue to influence the scientific community and pave the way for future research and applications.

Profile summary based on public USPTO records.